The science behind the silent killer. Here is how Inimmune is developing vaccines to help solve the opioid epidemic.
Read full article:
Recent Posts
- Inimmune receives Small Business Innovation Research Contract to develop novel treatments targeting Allergic Rhinitis.
- Inimmune Receives $598K Small Business Innovation Research Contract to Advance Vaccine Technologies
- Inimmune- Montana Ambassadors Business of the Year
- The Rise of Venture Capital in Montana
- For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance